HEALTHCARE

Drug selection and formulary management

A new drug may represent breakthrough in the treatment of a disease or it may be a small incremental change.  A new drug may also represent a balance of safety versus efficacy that is advantages or similar to existing drugs.  Let us help you tailor the drugs you use in your patient population to optimize your treatment coverage so that it is effective and affordable.

Leveraging patient information

Electronic health records not only provide a way to document patient care, but they also provide easily retrievable information that can be used in the care of patients.  This information can be used to identify immediate health care needs such as remotely monitored patients with abnormal diagnostic values or patients due for routine monitoring.  We provide guidance on custom designed alerts that work for you rather than cause work for you.
​

Evidenced Based Medicine

Evidenced based medicine is the use of the best available evidence to design a patient specific management plan.  It is not "cookbook" medicine, since each patient is unique and requires an individualized treatment plan.  Prescribe Right offers assistance in the application of innovative use of evidenced based medicine principles to help you provide the best care to your patients.  
​

INVESTORS

New Drug Market Potential

Prescribe Right can provide an comparison of a new drug to its drug class or therapeutic class.  Drugs may have advantages or disadvantages based on safety, efficacy, dosage form, route of administration, frequency or the presence or absence of special monitoring programs.  These along with price and availability are the primary drivers that influence the potential acceptance and use of a drug as compared to other drugs in its class or other treatments.
​

Product Portfolio Analysis

For investors interested in the entire line if products for a company rather than a single drug, Prescribe Right can provide an analysis of the strength and weakness of each drug in it's portfolio.  In comparison to the analysis of a single drug, the portfolio analysis provides an overview of of how drugs compare to major treatment alternatives.